Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SB-UF for Treating Uterine Fibroids in Pregnancy
NCT04762316Phase 4Completed
- Start
- Jan 2019
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4 trial of SB-UF in Uterine Fibroids (UF) (2 arms). Primary endpoint: Size of Uterine Fibroids at 40 weeks. Started Jan 2019; status: completed.
02
Drugs
SB-UF
03
Conditions
Uterine Fibroids (UF)
Beyond the preview
Go deeper on NCT04762316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04762316.